US Congress Senate Bill 771 (Prior Session Legislation)

---

Spectrum: Strong Partisan Bill (Democrat 15-1)
Status: Introduced on March 29 2017 - 25% progression, died in committee
Action: 2017-03-29 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Improving Access To Affordable Prescription Drugs Act This bill amends provisions of various laws relating to prescription-drug pricing and affordability. Specifically, the bill: expands reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance; adds reporting requirements for certain nonprofit patient-assistance programs; requires the Government Accountability Office (GAO) to report to Congress on the impact of patient-assistance programs on prescription-drug pricing and expenditures; requires the Centers for Medicare & Medicaid Services (CMS) to negotiate prices for certain prescription drugs under the Medicare program; requires the GAO to report to Congress on such negotiations conducted by the CMS; requires the Centers for Medicare and Medicaid Innovation within the CMS to test specified models for negotiating drug prices; establishes reporting requirements, and corresponding civil penalties for noncompliance, for pharmaceutical companies with respect to spikes in prescription-drug prices; establishes an excise tax on prescription drugs subject to price spikes; lessens prescription-drug cost-sharing requirements under qualified health plans, group health plans, and the Medicare program; modifies provisions related to the importation of prescription drugs; requires drug manufacturers to provide drug rebates for drugs dispensed to certain low-income individuals under the Medicare program; establishes a prize fund for new and more effective treatments of bacterial infections; establishes a Center for Clinical Research within the National Institutes of Health; modifies provisions related to drug exclusivity; allows the Federal Trade Commission to initiate enforcement proceedings against parties to an agreement resolving or settling a patent-infringement claim in connection with the sale of a drug product; requires the Food and Drug Administration to establish a database of generic drugs; and modifies other provisions related to generic drugs, prescription-drug advertising, and product hopping.

Improving Access To Affordable Prescription Drugs Act

Sen. Al Franken [D-MN]	Sen. Bernard Sanders [I-VT]	Sen. Sheldon Whitehouse [D-RI]	Sen. Sherrod Brown [D-OH]
Sen. Amy Klobuchar [D-MN]	Sen. Elizabeth Warren [D-MA]	Sen. Tammy Baldwin [D-WI]	Sen. Jack Reed [D-RI]
Sen. Kirsten Gillibrand [D-NY]	Sen. Margaret Hassan [D-NH]	Sen. Richard Durbin [D-IL]	Sen. Chris Van Hollen [D-MD]
Sen. Jeff Merkley [D-OR]	Sen. Tom Udall [D-NM]	Sen. Richard Blumenthal [D-CT]	Sen. Cory Booker [D-NJ]

Date	Chamber	Action
2017-03-29	Senate	Read twice and referred to the Committee on Finance.

HB1245 (Related) 2017-03-03 - Referred to the Subcommittee on Health.
HB1776 (Same As) 2017-04-05 - Referred to the Subcommittee on Health.
SB252 (Related) 2017-02-01 - Read twice and referred to the Committee on Finance.
SB348 (Related) 2017-02-09 - Read twice and referred to the Committee on Finance.
SB469 (Related) 2017-02-28 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB1688 (Related) 2017-08-01 - Read twice and referred to the Committee on Finance.
SB2478 (Related) 2018-03-01 - Read twice and referred to the Committee on Finance.
HB6340 (Related) 2018-07-11 - Referred to the House Committee on Energy and Commerce.
SB2476 (Related) 2018-02-28 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB3411 (Related) 2018-09-05 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/senate-bill/771/all-info
Text	https://www.congress.gov/115/bills/s771/BILLS-115s771is.pdf